| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.39B | +25.3% |
| Cost of Revenue | $442.5M | +74.5% |
| Gross Profit | $948.5M | +10.7% |
| R&D Expense | $959.5M | +37.9% |
| SG&A Expense | $373.3M | +7.3% |
| Operating Income | -$882.2M | -65.9% |
| Interest Expense | $7.4M | +554.6% |
| Pre-tax Income | -$882.4M | -66.1% |
| Income Tax | $37.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.49B | +40.7% |
| Short-term Investments | $101.7M | -85.1% |
| Accounts Receivable | $633.8M | +86.1% |
| Current Assets | $2.36B | +9.9% |
| Total Assets | $7.83B | +61.8% |
| Current Liabilities | $1.01B | +61.5% |
| Total Liabilities | $4.08B | +66.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.4M | +46.7% |
| Capital Expenditures | $57.1M | +36.2% |
| Investing Cash Flow | $723.2M | +139.4% |
| Financing Cash Flow | -$226.6M | -113.2% |
| Free Cash Flow | -$116.6M | +24.0% |
| +2591.6% |
| Net Income | -$921.1M | -72.9% |
| EPS (Basic) | -$2.96 | -56.6% |
| EPS (Diluted) | -$2.96 | -56.6% |
| Stockholders' Equity |
| $3.53B |
| +47.4% |